ELSE NUTRN HLDG BABYF
—
0.06
0.00
0.00%
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow BABYF
Growth Flags
show if company had growth for consecutive years
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.05 | 0.06 | 0.11 | 0.09 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(0.50) | (0.43) | 0.75 | (0.26) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.38 | 0.35 | 0.24 | 0.21 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(0.75) | (0.65) | (1.04) | (0.21) | |
EV/FCF |
(0.76) | (0.66) | (1.10) | (0.21) | |
Quick Ratio |
0.19 | 0.12 | 0.20 | 0.20 | |
Current Ratio |
0.39 | 0.38 | 0.69 | 0.79 | |
Net Debt/EBITDA |
(2.89) | (0.62) | (1.53) | (0.61) | |
Debt/Assets |
62.42% | 59.51% | 21.03% | 18.38% | |
Debt/Equity |
(0.49) | (0.46) | (0.67) | (1.28) | |
Asset Turnover |
1.16 | 1.11 | 0.89 | 0.79 | |
Operating CF/Net income |
0.87 | 0.26 | (1.59) | 1.61 | |
Capex/Depreciation |
0.00 | (0.50) | 0.01 | 0.03 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1.16% | (0.30%) | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
67.05% | 182.42% | 58.90% | 77.34% | |
Intangible Assets out of Total Assets |
0.04 | 0.05 | 0.04 | 0.03 | |
Share Based Compensation of Revenue |
0.07% | (1.18%) | 0.31% | 0.49% | |
Graham Net Nets |
(18.18) | (11.57) | (2.49) | (1.92) | |
Graham Number |
7.21 | 9.12 | 4.54 | 4.08 | |
Earnings Yield |
(8,603.50%) | (5,426.75%) | (2,458.14%) | (3,222.93%) | |
Free Cash Flow Yield |
(1,089.94%) | (820.72%) | (198.59%) | (1,128.95%) | |
Revenue per Share |
0.24 | 0.17 | 0.32 | 0.36 | |
Operating CF per Share |
(0.08) | (0.19) | 0.19 | (0.55) | |
Capex per Share |
0.00 | (0.01) | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.08) | (0.19) | 0.19 | (0.55) | |
Cash per Share |
0.04 | 0.04 | 0.02 | 0.02 | |
Shareholders Equity per Share |
(0.67) | (0.85) | (0.27) | (0.16) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.67) | (0.85) | (0.27) | (0.16) | |
Free Cash Flow |
(0.35) | (0.66) | 0.70 | (1.67) | |
Working Capital |
(3.23) | (3.17) | (1.30) | (0.82) | |
Capital Expenditures |
— | (0.02) | 0.00 | 0.00 | |
Net Current Asset Value |
(3.23) | (3.17) | (1.30) | (0.82) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.04 | 0.00 | 0.00 | |
Net Profit Margin |
(37.91%) | (438.01%) | (36.18%) | (95.87%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.89 | 0.72 | 1.04 | 1.25 | |
Average Payables |
1.69 | 1.74 | 1.15 | 1.45 | |
Average Inventory |
2.02 | 2.56 | 3.47 | 3.85 | |
Average Assets |
3.39 | 3.88 | 5.31 | 6.11 | |
Average Common Equity |
(1.64) | (0.82) | 1.34 | 0.34 |
Columns are period end dates